Your browser doesn't support javascript.
loading
New insights into the burden and costs of multiple sclerosis in Europe: Results for Hungary.
Péntek, Márta; Kobelt, Gisela; Berg, Jenny; Capsa, Daniela; Dalén, Johan; Bíró, Zita; Mátyás, Klotild; Komoly, Sámuel.
Afiliación
  • Péntek M; Corvinus University of Budapest, Budapest, Hungary.
  • Kobelt G; European Health Economics, Mulhouse, France.
  • Berg J; Mapi Group, Stockholm, Sweden.
  • Capsa D; Mapi Group, Stockholm, Sweden.
  • Dalén J; Mapi Group, Stockholm, Sweden.
  • Bíró Z; Flór Ferenc County Hospital, Kistarcsa, Hungary.
  • Mátyás K; Markhot Ferenc Teaching Hospital, Eger, Hungary.
  • Komoly S; University of Pécs, Pécs, Hungary.
Mult Scler ; 23(2_suppl): 91-103, 2017 Aug.
Article en En | MEDLINE | ID: mdl-28643591
INTRODUCTION: To estimate the value of interventions in multiple sclerosis (MS) - where lifetime costs and outcomes cannot be observed - outcome data have to be combined with costs. This requires that cost data be regularly updated. OBJECTIVES AND METHODS: This study is part of a cross-sectional retrospective study in 16 countries collecting data on resource consumption, work capacity, health-related quality of life (HRQoL) and prevalent symptoms for patients with MS. Descriptive analyses are presented by level of disability, from the societal perspective, in HUF 2015. RESULTS: A total of 521 patients (mean age 47 years) participated; 85% were below retirement age, and of these, 47% were employed. Employment was related to disability and MS affected productivity at work for 82% of those working. Overall, 94% and 66% of patients experienced fatigue and cognitive difficulties as a problem, respectively. The mean utility and annual costs were 0.691 and 3,432,000HUF at Expanded Disability Status Scale (EDSS) 0-3, 0.491 and 5,262,000HUF at EDSS 4-6.5 and 0.076 and 6,235,000HUF at EDSS 7-9, respectively. The average cost of a relapse was estimated at 240,500HUF. CONCLUSION: This study illustrates the burden of MS on Hungarian patients and provides current data that are important for the development of health policies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Costos de la Atención en Salud / Costo de Enfermedad / Empleo / Esclerosis Múltiple Tipo de estudio: Health_economic_evaluation / Observational_studies / Prevalence_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude / Patient_preference Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Hungria Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Costos de la Atención en Salud / Costo de Enfermedad / Empleo / Esclerosis Múltiple Tipo de estudio: Health_economic_evaluation / Observational_studies / Prevalence_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude / Patient_preference Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Hungria Pais de publicación: Reino Unido